Relevant to VERIFIED Q2 2026 approved — here is my latest bloodwork comparison:
Key improvements: A1C 7.6% → 5.5%, triglycerides 217 → 117 mg/dL, hsCRP 8.0 → 1.1 mg/L. All on tirzepatide for 9 months.
The inflammatory marker drop is what impresses me most. Consistent with the SELECT trial's cardiovascular findings.
Want to share my personal experience related to VERIFIED Q2 2026 approved since I think it might help others in a similar situation.
I started my GLP-1 journey in March 2025 at 273 lbs with metabolic syndrome. My telehealth provider prescribed semaglutide 0.25mg to start.
Now, 10 months later: I am down 73 lbs, my labs have normalized, and my sleep apnea has improved dramatically. The VERIFIED Q2 2026 aspect specifically was something that made a big difference in my journey.
This forum was my go-to resource throughout.
anders_CPH — that is really helpful context on VERIFIED Q2 2026 approved. Follow-up question: did you change anything about your diet at the same time?
I am in a similar situation (month 2) and trying to set realistic expectations.
Want to share my personal experience related to VERIFIED Q2 2026 approved since I think it might help others in a similar situation.
I started my GLP-1 journey in October 2024 at 245 lbs with prediabetes and hypertension. My endocrinologist prescribed semaglutide 0.25mg to start.
Now, 16 months later: I am down 80 lbs, my labs have normalized, and I am off 2 of my 3 medications. The VERIFIED Q2 2026 aspect specifically was something that made a big difference in my journey.
This community helped me every step of the way.
anders_CPH — that is really helpful context on VERIFIED Q2 2026 approved. Follow-up question: did you experience any side effects during this phase?
I am in a similar situation (about to start) and trying to set realistic expectations.